Filing Details
- Accession Number:
- 0001127602-13-009691
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-06 17:35:59
- Reporting Period:
- 2013-03-05
- Filing Date:
- 2013-03-06
- Accepted Time:
- 2013-03-06 17:35:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190632 | J Stephen Ryan | 2525 Dupont Drive Irvine CA 92612 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-03-05 | 5,700 | $60.60 | 10,970 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-03-05 | 5,700 | $110.00 | 5,270 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Nonemployee Director Stock Option (Right to Buy) | Disposition | 2013-03-05 | 5,700 | $0.00 | 5,700 | $60.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-05-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 42,613 | Indirect | By Living Trust |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 26, 2012.
- Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan.
- S & A Ryan Living 1994 Trust, in which the reporting person has a pecuniary interest and of which the reporting person and his spouse are each trustees.
- Option is fully vested and exercisable on the date of the next regular annual meeting of stockholders of Allergan, Inc. at which directors are to be elected following the date of grant.